Renaissance Capital logo

TXG News

Hard times for SoftBank in the IPO market

10x Genomics logo

The We Company (WE) isn’t SoftBank’s only dud. SoftBank has been a principal shareholder on two US IPOs this year, both of which are now underwater. This week’s IPO of Chinese software platform OneConnect Financial Technology...read more

The Top IPO Profiles on IPO Pro in 3Q 2019

10x Genomics logo

At the end of each quarter, we look back at the most viewed profiles on IPO Pro. In 3Q 2019, the ten companies below – from a data monitoring and analytics provider, to an at-home fitness unicorn – have led the quarter and piqued the curiosity of IPO...read more

Healthcare and Tech Industries Led IPO Activity in the 3Q

10x Genomics logo

Almost two-thirds of all IPOs in the 3Q were healthcare or tech, along with 7 of the top 10 best-performing IPOs. The healthcare sector had 14 offerings raise $4.0 billion; deal flow was driven by biotechs (7) and diagnostics companies (3), while two dental...read more

Renaissance Capital's 3Q 2019 US IPO Market Review

10x Genomics logo

The IPO Party Is Cut Short The third quarter started off in high spirits but ended with a hangover. During the quarter, 39 deals raised $10.8 billion, down slightly from last year, but above...read more